Sean M. Doherty - 17 May 2022 Form 4 Insider Report for Provention Bio, Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 17 May 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 May 2022, 18:05:20 UTC
Prior SEC filing: 14 May 2021
Source filing: View source filing
Reporting owner signature: /s/ Thierry Chauche, as attorney-in-fact

Key filing fact

Sean M. Doherty filed Form 4 for Provention Bio, Inc. on 18 May 2022.

Key facts

This page summarizes Sean M. Doherty's Form 4 filing for Provention Bio, Inc..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 18 May 2022, 18:05.

Change

Previous filing in this sequence was filed on 14 May 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PRVB transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +33,000
Change %
Price: $0.000000
Shares after: 33,000
Date: 17 May 2022
Ownership: Direct
Underlying class: Common Stock, par value $0.0001
Underlying amount: 33,000
Exercise price: $4.52
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The options will vest in full and become exercisable upon the earlier to occur of (a) the business day before the Issuer's next annual meeting of stockholders and (b) May 17, 2023.

Footnote F2

The securities were granted pursuant to the Issuer's Amended and Restated 2017 Equity Incentive Plan.

SEC remarks

Exhibit 24.1 - Power of Attorney